Profiles for generic drugs starting with 's'
✉ Email this page to a colleague
US Patents and Regulatory Information for s
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actelion | UPTRAVI | selexipag | TABLET;ORAL | 207947-001 | Dec 21, 2015 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Strides Pharma | SEVELAMER CARBONATE | sevelamer carbonate | FOR SUSPENSION;ORAL | 211917-001 | Sep 8, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Msn | SOLIFENACIN SUCCINATE | solifenacin succinate | TABLET;ORAL | 210688-002 | May 20, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |